A previous study has found that the expression of GLI2 was significantly higher in PC than in benign prostate hyperplasia, decreased after androgen ablation in a limited time window but became highly expressed again in CRPC [25]. The gene discussed is GLI2; the disease is benign prostatic hyperplasia.